Zelluna ASA (OSTO:ULTIO) ROE % Adjusted to Book Value : -311.75% (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Zelluna ASA ROE % Adjusted to Book Value?

Zelluna ASA's ROE % for the quarter that ended in Dec. 2024 was -314.87%. Zelluna ASA's PB Ratio for the quarter that ended in Dec. 2024 was 1.01. Zelluna ASA's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -311.75%.

Zelluna ASA ROE % Adjusted to Book Value Historical Data

The historical data trend for Zelluna ASA's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zelluna ASA ROE % Adjusted to Book Value Chart

Zelluna ASA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-7.36

-4.59

-3.96

-3.49

-109.96

Zelluna ASA Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-4.94	-34.84	-56.07	-158.06	-311.75

Competitive Comparison of Zelluna ASA's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Zelluna ASA's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zelluna ASA's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zelluna ASA's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Zelluna ASA's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Zelluna ASA ROE % Adjusted to Book Value Calculation

Zelluna ASA's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-111.06%	/	1.01
	=	-109.96%

Zelluna ASA's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-314.87%	/	1.01
	=	-311.75%

Zelluna ASA ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Zelluna ASA's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Zelluna ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zelluna ASA (OSTO:ULTIo) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

ZLNA:Norway 7UM:Germany

Address

Ullernchausseen 64, Oslo, NOR, 0379

Website

https://www.zelluna.com

Ultimovacs ASA is a pharmaceutical company involved in developing novel immunotherapies against cancer. Its product candidate is UV1, a peptide-based vaccine inducing T cell responses against the universal cancer antigen telomerase. The company and its proprietary technology are based on preclinical and clinical research on immunotherapies conducted at the Oslo University Hospital.

Zelluna ASA Headlines

No Headlines